Anne-Claire Simon
Overview
Explore the profile of Anne-Claire Simon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
91
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Savale L, Guimas M, Ebstein N, Fertin M, Jevnikar M, Renard S, et al.
J Hepatol
. 2020 Sep;
73(5):1293-1294.
PMID: 32907706
No abstract available.
2.
Savale L, Guimas M, Ebstein N, Fertin M, Jevnikar M, Renard S, et al.
J Hepatol
. 2020 Mar;
73(1):130-139.
PMID: 32145258
Background & Aims: Long-term outcomes in portopulmonary hypertension (PoPH) are poorly studied in the current era of pulmonary hypertension management. We analysed the effect of pulmonary arterial hypertension (PAH)-targeted therapies,...
3.
Guilhem A, Fargeton A, Simon A, Duffau P, Harle J, Lavigne C, et al.
PLoS One
. 2017 Dec;
12(11):e0188943.
PMID: 29190827
Background: Bevacizumab, an anti-VEGF monoclonal antibody, has recently emerged as a new option for severe forms of hereditary hemorrhagic telangiectasia (HHT). Its utilization in this orphan disease has rapidly spread...
4.
Revuz S, Decullier E, Ginon I, Lamblin N, Hatron P, Kaminsky P, et al.
PLoS One
. 2017 Oct;
12(10):e0184227.
PMID: 28981519
Background: Different pulmonary hypertension (PH) mechanisms are associated with hereditary haemorrhagic telangiectasia (HHT). Methods And Results: We conducted a retrospective study of all suspected cases of PH (echocardiographically estimated systolic...